Jason Lohmueller

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Patent
    Ineligible company:
    Coeptis Therapeutics
    Date added:
    09/10/2024
    Date updated:
    09/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock
    Ineligible company:
    GenCART, Inc.
    Date added:
    09/10/2024
    Date updated:
    09/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Other Business Ownership
    Ineligible company:
    Monarch Therapeutics
    Date added:
    09/10/2024
    Date updated:
    09/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    UPMC Enterprises
    Date added:
    09/10/2024
    Date updated:
    09/10/2024
  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Coeptis Therapeutics
    Date added:
    09/10/2024
    Date updated:
    09/10/2024
    Relationship end date:
    12/31/2024
  • Attribution:
    Self
    Type of financial relationship:
    Stock Options
    Ineligible company:
    NeoCell Technologies
    Date added:
    09/10/2024
    Date updated:
    09/10/2024
  • Attribution:
    Self
    Type of financial relationship:
    Professional Services
    Ineligible company:
    NeoCell Technologies
    Date added:
    09/10/2024
    Date updated:
    09/10/2024
  • Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    GenCART Inc.
    Date added:
    09/10/2024
    Date updated:
    09/10/2024
    Relationship end date:
    09/30/2024
  • Attribution:
    Self
    Type of financial relationship:
    Patent
    Ineligible company:
    Monarch Therapeutics
    Date added:
    09/10/2024
    Date updated:
    09/10/2024
Return to 4th Binaytara Precision Oncology Summit: Current Standards and Emerging Therapies